Innovation Fund Application to the Multicenter AIDS Cohort Study MACS/WIHS Combined Cohort Study (MWCCS) COVID-19 Vaccine Acceptance and Hesitancy (CVHB) Study in People with HIV

$26,713U01FY2021HLNIH

Univ Of North Carolina Chapel Hill, Chapel Hill NC

Investigators

Linked publications, trials & patents

Paper 39720558 Paper 39431507 Paper 39327860 Paper 39315264 Paper 39288937 Paper 39110550 Paper 38947061 Paper 38905486 Paper 38905479 Paper 38905473 Paper 38864119 Paper 38720636 Paper 38703339 Paper 38680610 Paper 38670612 Paper 38643166 Paper 38612641 Paper 38600088 Paper 38507583 Paper 38498872 Paper 38466776 Paper 38408732 Paper 38327572 Paper 38294704 Paper 38239974 Paper 38236978 Paper 38224361 Paper 38215160 Paper 38214547 Paper 38180885 Paper 38133580 Paper 38131623 Paper 38126350 Paper 38110289 Paper 38086007 Paper 38079241 Paper 38024328 Paper 37976419 Paper 37956200 Paper 37861689 Paper 37843370 Paper 37773048 Paper 37757864 Paper 37741499 Paper 37656704 Paper 37645749 Paper 37643897 Paper 37609144 Paper 37548977 Paper 37500684 Paper 37484940 Paper 37437108 Paper 37418062 Paper 37410084 Paper 37352734 Paper 37352493 Paper 37317962 Paper 37276144 Paper 37237391 Paper 37205656 Paper 37199567 Paper 37179294 Paper 37155639 Paper 37067613 Paper 37067469 Paper 37005072 Paper 36989497 Paper 36988544 Paper 36974507 Paper 36922393 Paper 36883578 Paper 36804871 Paper 36757336 Paper 36747684 Paper 36728933 Paper 36728912 Paper 36722801 Paper 36656093 Paper 36655189 Paper 36594946 Paper 36541641 Paper 36541638 Paper 36417366 Paper 36415908 Paper 36380689 Paper 36318895 Paper 36224218 Paper 36222655 Paper 36215981 Paper 36184972 Paper 36129038 Paper 36099481 Paper 36083508 Paper 36053091 Paper 36044614 Paper 35969468 Paper 35951669 Paper 35950945 Paper 35950940 Paper 35903868

Abstract

MWCCS participants are a high-risk group for severe COVID-19 disease in terms of being HIV-infected, predominately of elderly age, and having numerous underlying comorbidities. Therefore, it is imperative for their health that they be vaccinated with the new COVID-19 vaccines. To date, however, there are only anecdotal data on COVID-19 vaccine acceptance and efficacy in people with HIV (PWH). The MWCCS is ideal for analyzing (a) the acceptancy and effects of COVID-19 vaccine(s) in male and female PWH and matched HIV-uninfected controls (HUC), (b) the impact of age and co-morbidities on vaccine immune response and protection against COVID-19, and (c) the social, economic, and behavioral changes after COVID-19 immunization as compared to the individuals who opted to not take the vaccine.

View original record on NIH RePORTER →